Fresenius

Fresenius successfully placed €1.0 billion of Schuldschein Loans. Given the substantial investor demand, the volume of the issuance was significantly upsized. The Schuldschein Loans were issued in tranches of five, seven and ten years with fixed and variable interest rates. The proceeds will be used general corporate purposes and the acquisition of Quirónsalud. Funding of the transaction will be on January 31, 2017. More than 230 investors participated. The placement was arranged by Bayerische Landesbank, Deutsche Bank AG, DZ BANK and NORD/LB Norddeutsche Landesbank Girozentrale.

Heparin Sodium, an anticoagulent, is now available in the company’s Simplist™ ready-to-administer prefilled syringe in the United States. This marks the second new product launch for the Simplist™ line following ownership by Fresenius Kabi. The launch expands Fresenius Kabi’s overall Heparin portfolio.
CATSmart is Fresenius Kabi’s next-generation continuous autotransfusion system, which helps reduce blood loss during surgery. CATSmart will be distributed in the U.S. by Terumo Cardiovascular Group. Fresenius Kabi USA and Terumo Cardiovascular Group have signed an exclusive, five-year distribution agreement for CATSmart.
February 18

February 18, 2017
Orlando, Florida, USA

ASPEN/CNW

American Society for Parenteral and Enteral Nutrition

18.02. - 21.02.2017

Event website
Import (ICS)

NEXT EVENT

March 21

March 21, 2017
Brussels, Belgium

ISICEM

37th International Symposium on Intensive Care and Emergency Medicine

21.03. - 24.03.2017

Event website
Import (ICS)

NEXT EVENT

March 11

March 11, 2017
Long Beach, California, USA

37th Annual International Peritoneal Dialysis Conference

11.03. - 14.03.2017

Event website
Import (ICS)

NEXT EVENT

January 30

January 30, 2017
Dubai, UAE

Arab Health Congress 2017

30.01. - 02.02.2017

Event website
Import (ICS)

NEXT EVENT

Conference Call Q3 2017, Fresenius

November 02, 2017 - 02:00 pm - 00:00 am
Bad Homburg, Germany

Conference Call Q3 2017, Fresenius

Investor News Presentation Podcast Import (ICS)
Conference Call Q2/2017, Fresenius

August 01, 2017 - 02:00 pm - 00:00 am
Bad Homburg, Germany

Conference Call Q2/2017, Fresenius

Live webcast

Investor News Presentation Transcript Podcast Import (ICS)

Tigecycline, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

Subscribe to